Australia’s competition watchdog is taking court action against the drug company Pfizer for allegedly misusing its market power to sell cholesterol-lowering medication to pharmacies.
The allegations relate to the company’s conduct in the months before May 2012, when Pfizer’s cholesterol-lowering drug Lipitor came ”off patent”, allowing competitors to enter the market and supply cheaper generic versions. Sydney Morning Herald – Read more…
The allegations relate to the company’s conduct in the months before May 2012, when Pfizer’s cholesterol-lowering drug Lipitor came ”off patent”, allowing competitors to enter the market and supply cheaper generic versions. Sydney Morning Herald – Read more…